Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PsiOxus Therapeutics
Biotech
J&J's Mammen abruptly leaves top R&D job—Chutes & Ladders
J&J's Mammen abruptly leaves top R&D post. Biden taps Bertagnolli to be first woman director of the NCI. Lilly names new COO for oncology wing.
Max Bayer
,
Gabrielle Masson
Aug 12, 2022 9:30am
Bluebird shows oncolytic virus boosts CAR-T in solid tumors
Apr 14, 2021 8:55am
BMS, PsiOxus add an asset to Opdivo-oncolytic virus combo deal
Apr 7, 2021 10:18am
PsiOxus lures Lillie from Merck to fill CMO position
Mar 5, 2020 8:45am
New discoveries in brain diseases, immuno-oncology—News of Note
Nov 19, 2018 11:17am
PsiOxus gets $15M milestone for BMS-backed cancer therapy
Dec 12, 2017 9:26am
